chr16:69355567:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr16:69,389,470-69,419,910 |
| hg38 | chr16:69,355,567-69,386,007 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| <0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
| 0.002 | Cardiovascular Diseases | NA | GAD | Detail | |
| 0.002 | Cerebrovascular Disorders | NA | GAD | Detail | |
| <0.001 | ulcerative colitis | NA | BeFree | Detail | |
| <0.001 | colorectal carcinoma | NA | BeFree | Detail | |
| <0.001 | Crohn Disease | NA | BeFree | Detail | |
| <0.001 | Diabetes Mellitus, Non-Insulin-Dependent | NA | BeFree | Detail | |
| <0.001 | Fanconi anemia | NA | BeFree | Detail | |
| <0.001 | glioblastoma | Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblast... | BeFree | 24909307 | Detail |
| <0.001 | Heart failure | NA | BeFree | Detail | |
| <0.001 | congestive heart failure | NA | BeFree | Detail | |
| <0.001 | HIV Infections | NA | BeFree | Detail | |
| <0.001 | Inflammatory Bowel Diseases | NA | BeFree | Detail | |
| <0.001 | leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
| 0.123 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.002 | Chronic Obstructive Airway Disease | NA | GAD | Detail | |
| 0.003 | lymphoma | NA | BeFree,LHGDN | Detail | |
| 0.002 | Malignant neoplasm of stomach | The lowest expression levels of TRF1 and TRF2 were associated with MSI-H gastric... | BeFree | 25486025 | Detail |
| <0.001 | melanoma | NA | BeFree | Detail | |
| <0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
| <0.001 | multiple myeloma | NA | BeFree | Detail | |
| <0.001 | Neoplasm Metastasis | NA | BeFree | Detail | |
| <0.001 | nephroblastoma | We reveal here that TRF2 is expressed in the vasculature of most human cancer ty... | BeFree | 25437559 | Detail |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | breast carcinoma | Several TL-related single nucleotide polymorphisms had modest association with b... | BeFree | 23629941 | Detail |
| <0.001 | Skin Neoplasms | NA | BeFree | Detail | |
| 0.003 | Stomach Neoplasms | NA | LHGDN | Detail | |
| 0.008 | Malignant neoplasm of breast | Several TL-related single nucleotide polymorphisms had modest association with b... | BeFree | 23629941 | Detail |
| <0.001 | acute leukemia | NA | BeFree | Detail | |
| <0.001 | Dysplastic Nevus | NA | BeFree | Detail | |
| <0.001 | Premature aging syndrome | NA | BeFree | Detail | |
| 0.005 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
| <0.001 | Chronic heart failure | NA | BeFree | Detail | |
| <0.001 | Iron Overload | NA | BeFree | Detail | |
| <0.001 | Superficial ulcer | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Nijmegen breakage syndrome | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | NA | BeFree | Detail | |
| 0.002 | Carcinogenesis | Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblast... | BeFree | 24909307 | Detail |
| <0.001 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| 0.001 | colon carcinoma | NA | BeFree | Detail | |
| 0.002 | stomach carcinoma | The lowest expression levels of TRF1 and TRF2 were associated with MSI-H gastric... | BeFree | 25486025 | Detail |
| <0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Cockayne Syndrome, Type II | NA | BeFree | Detail | |
| <0.001 | Advanced cancer | NA | BeFree | Detail | |
| <0.001 | precancerous lesions | NA | BeFree | Detail | |
| <0.001 | Precursor B-cell lymphoblastic leukemia | NA | BeFree | Detail | |
| <0.001 | Invasive Carcinoma | NA | BeFree | Detail | |
| <0.001 | Desmoplastic | NA | BeFree | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Non-Neoplastic Disorder | NA | BeFree | Detail | |
| <0.001 | uterine corpus cancer | NA | BeFree | Detail | |
| 0.003 | liver carcinoma | NA | BeFree,GAD | Detail | |
| <0.001 | Promyelocytic leukemia | NA | BeFree | Detail | |
| <0.001 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | NA | BeFree | Detail | |
| 0.002 | Alcoholic Intoxication, Chronic | NA | GAD | Detail | |
| 0.003 | aplastic anemia | NA | BeFree,GAD | Detail | |
| <0.001 | Ataxia | NA | BeFree | Detail | |
| <0.001 | Tooth Attrition | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
| 0.008 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
| <0.001 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of endometrium | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinom... | BeFree | 25730259 | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The lowest expression levels of TRF1 and TRF2 were associated with MSI-H gastric cancers (P = 0.008 ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We reveal here that TRF2 is expressed in the vasculature of most human cancer types, where it coloca... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Several TL-related single nucleotide polymorphisms had modest association with breast cancer risk ov... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Several TL-related single nucleotide polymorphisms had modest association with breast cancer risk ov... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Molecular targeting of TRF2 suppresses the growth and tumorigenesis of glioblastoma stem cells. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The lowest expression levels of TRF1 and TRF2 were associated with MSI-H gastric cancers (P = 0.008 ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Over-expression of telomere binding factors (TRF1 & TRF2) in renal cell carcinoma and their inhibiti... | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs93886 dbSNP
- Genome
- hg38
- Position
- chr16:69,355,567-69,386,007
- Variant Type
- snv
Genome browser